Related Experiment Video
Updated: Aug 16, 2026

Screening Ion Channels in Cancer Cells
Published on: June 16, 2023
Pharmacological modulation of lung cancer cells for potassium ion depletion
Britta Andersson1, Parviz Behnam-Motlagh, Roger Henriksson
1Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden.
Background:
Depletion of intracellular potassium ions (K+) is necessary for cells to shrink, induce DNA fragmentation and activate caspases, events which are features of apoptosis.
Materials And Methods:
We used 86Rb+ as a K+ analogue to evaluate the possibility of pharmacologically depleting human pulmonary mesothelioma (P31) and small cell lung cancer (U1690) cells of K+, for future use in studies of apoptosis induction.
Results:
The Na+, K+, 2CI(-)-cotransport inhibitor bumetanide transiently inhibited 86Rb+ influx, but when combined with the Na+, K+, ATPase pump inhibitor ouabain there was a marked and lasting (up to 6 h) 86Rb+ influx inhibition. Cellular K+ efflux was augmented by amphotericin B, digitonin and nigericin. Amphotericin B was an effective 86Rb+ efflux stimulator with low cytotoxicity, whereas digitonin caused cell detachment and nigericin increased LDH release in the U1690 cell line, indicating considerable toxicity of the drugs.
Conclusion:
It is possible to efficiently reduce intracellular K+ by persistent K+ influx inhibition and simultaneous K+ efflux stimulation with clinically available drugs.
Insights
Pharmacologically depleting cancer cells of potassium (K+) is achievable. Combining influx inhibitors with efflux stimulators effectively reduces intracellular K+ for apoptosis studies.
Area of Science:
- Cell Biology
- Cancer Research
- Pharmacology
Background:
- Intracellular potassium ion (K+) depletion is crucial for apoptosis.
- Apoptotic features include cell shrinkage, DNA fragmentation, and caspase activation.
Purpose of the Study:
- To investigate pharmacological methods for depleting K+ in human pulmonary mesothelioma (P31) and small cell lung cancer (U1690) cells.
- To assess the potential for K+ depletion in future apoptosis induction studies.
Main Methods:
- Utilized 86Rubidium (86Rb+) as a K+ analogue to measure ion transport.
- Employed Na+, K+, 2Cl(-)-cotransport inhibitor bumetanide and Na+, K+-ATPase pump inhibitor ouabain to inhibit K+ influx.
- Used amphotericin B, digitonin, and nigericin to stimulate K+ efflux.
Main Results:
- Combined bumetanide and ouabain markedly and persistently inhibited 86Rb+ influx (up to 6 hours).
- Amphotericin B, digitonin, and nigericin augmented cellular K+ efflux.
- Amphotericin B showed effective 86Rb+ efflux stimulation with low cytotoxicity, unlike digitonin and nigericin which exhibited significant toxicity.
Conclusions:
- Efficient reduction of intracellular K+ in cancer cells is feasible.
- This can be achieved through sustained K+ influx inhibition combined with K+ efflux stimulation.
- Clinically available drugs can be utilized for this purpose in apoptosis research.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
11:13Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...